Pure Global AI
ANVISA registration 80020690491Active

ANTI-PEPTÍDEO CITRULINADO CÍCLICO (ANTI-CCP)

ANVISA Registration Number: 80020690491BIO-RAD LABORATORIOS BRASIL LTDABIO-RAD LABORATORIES, INCRisk Class II
Device names
Technical name
ANTI-PEPTÍDEO CITRULINADO CÍCLICO (ANTI-CCP)
Commercial name
Família BioPlex 2200 Anti-CCP
Risk class
Class II
Registration details
Registration Number
80020690491
Process Number
25351156240202656
CNPJ
03188198000177
Company information
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Sep 28, 2026
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for ANTI-PEPTÍDEO CITRULINADO CÍCLICO (ANTI-CCP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80020690491 and manufactured by BIO-RAD LABORATORIES, INC. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.